INSKIN Cosmedics Group has paid $37,800 in penalties for alleged supply and advertising an unapproved dermapen device.
The Dermapen 4, which at the time in question was not included on the Australian Register of Therapeutic Goods, was supplied on the occasions of 22 Feb and 17 May 2019, and was also advertised.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Feb 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Feb 20
